1 / 10

3D Printed Drugs Market

Global 3D Printed Drugs Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2027

omrglobal
Download Presentation

3D Printed Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global 3D Printed Drugs Market Research and Forecast 2018-2027 Pharmaceuticals Biotechnology

  2. DEFINITION The global 3D Printed Drugs market is still more research-based entity and with approval and commercialization of 3D printed drugs the market is expected to gain momentum in next decade (2017-2027). 3D printing as a technology in already has a broad reach and widely used in industries such as automobile, healthcare (primarily in dental and ortho), and retail. In the late 1980s, 3D printing (3DP) technology was developed at the Massachusetts Institute of Technology (MIT) as a rapid-prototyping technique. In this technology, an aqueous fluid is used to bind multiple layers of powder to create a wide range of drugs. 3D printed drugs are used to fuel innovation and progress across pharmaceutical industries.

  3. MARKET  MOTIVATORS • Drawbacks of conventional pharmaceutical unit operations • high prevalence of chronic diseases such as arthritis, asthma, cancer and diabetes • integration of 3d printing with conventional pharmaceutical technologies • growing usage of 3d printing technology in healthcare • high demand of instantaneous soluble tablets

  4. MARTET RESTRAINTS • Continuous clinical development of 3d printing requires high investment • Complex clinical trial protocols

  5. MARKET OPPORTUNITIES • Increase in healthcare investment in emerging nations • rising demand of medicine customization and personalization

  6. REGIONAL ANALYSIS

  7. MARKET SEGMENTATION By dosage forms • tablet • capsules • multi-drug implant • nanoparticles • solutions • nanosuspension • encapsulated within a polymer • implant

  8. MARKET SEGMENTATION By technology • inkjet printing • direct-write • zip dose • thermal inkjet (tij) printing • fused deposition modelling (fdm) • powder bed printing • stereolithography (sla)

  9. COMPANY PROFILES • Aprecia pharmaceuticals, llc. • Cycle pharmaceuticals ltd. • Fabrx ltd. • Glaxosmithkline plc • linx printing technologies To be continued…

  10. FOR MORE DETAILS PLEASE VISIT OUR WEBSITE CONTACT US Orion Market Research Pvt. Ltd. (OMR Global)116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya PradeshIndia- 452010 Global +1 646-755-7667 Asia +91 917-982-8694 info@omrglobal.com https://www.omrglobal.com 10

More Related